Direct cost of ambulatory care of type 2 diabetes in the middle and high income group populace of Delhi: the DEDICOM survey

To estimate the direct cost of ambulatory care in diabetes patients in the middle and high income group populace of Delhi. We analyzed the drugs, investigations, consultation and monitoring related data available from a survey of 35- 65-year-old known diabetes patients conducted using a probability-...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the Association of Physicians of India Vol. 56; p. 667
Main Authors: Kumar, A, Nagpal, J, Bhartia, A
Format: Journal Article
Language:English
Published: India 01.09.2008
Subjects:
Adult
Aged
Ambulatory Care - economics
Cluster Analysis
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - economics
Diabetes Mellitus, Type 2 - epidemiology
Female
Health Care Costs
Health Care Surveys
Humans
Hypoglycemic Agents - therapeutic use
Income
India - epidemiology
Linear Models
Male
Middle Aged
Socioeconomic Factors
Surveys and Questionnaires
India
ISSN:0004-5772
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To estimate the direct cost of ambulatory care in diabetes patients in the middle and high income group populace of Delhi. We analyzed the drugs, investigations, consultation and monitoring related data available from a survey of 35- 65-year-old known diabetes patients conducted using a probability-proportionate-to-size 2-stage cluster design to calculate the direct cost of ambulatory diabetes care. A total of 819 subjects were enrolled from 20,666 houses. The average estimate of direct annual expenditure on ambulatory care of diabetes was approximately Rs. 6000 (approximately US$ 150). Time elapsed since diagnosis (p<0.001), education (p=0.011), gross family income (p=0.002), presence of co-morbidities (p=0.009) and requirement for useof oral hypoglycemic agents (p<0.001) or insulin (p<0.001) were significant correlates. Direct ambulatory cost of care comprised 1-3% of the gross family income of the subjects. Despite the limitations of the present study it may be concluded that a majority of the diabetes patients spend a significant proportion of their family income on diabetes related expenditure. The cost is higher for subjects with longer duration since diagnosis, those with higher education or income, those with co-morbidities and those requiring oral hypoglycemic agents or insulin.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0004-5772